Is Merck Stock a Top Buy Right Now?
Several big pharma stocks delivered market-beating returns during the last bull market. An innovation boom in biologic therapies, an aging global population, and favorable reimbursement terms in the U.S. fueled this near industrywide upswing.
The titans of pharma may have a tougher go of it in the next bull market, however. Scores of top-selling biologic therapies are poised to lose market exclusivity during the current decade, and drug prices in the U.S. have become a central topic of debate in the political realm.
Image Source: Getty Images.
Source Fool.com
